Signaling mechanisms in the regulation of renal matrix metabolism in diabetes

Experimental Diabetes Research

Volumn 2012, Issue , 2012, Pages

  Mariappan, Meenalakshmi M ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRONECTIN; LAMININ; MESSENGER RNA; MICRORNA; RIBOSOME RNA; TRANSCRIPTION FACTOR;

BIOGENESIS; DIABETIC NEPHROPATHY; DISEASE COURSE; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; HYPERGLYCEMIA; KIDNEY; KIDNEY DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN SYNTHESIS; REVIEW; RIBOSOME; RNA TRANSLATION; SIGNAL TRANSDUCTION; UPREGULATION; EXTRACELLULAR MATRIX; METABOLISM; PHYSIOLOGY;

DIABETIC NEPHROPATHIES; EXTRACELLULAR MATRIX; HUMANS; KIDNEY; SIGNAL TRANSDUCTION;

EID: 84858307317     PISSN: 16875214     EISSN: 16875303     Source Type: Journal    
DOI: 10.1155/2012/749812     Document Type: Review

References (115)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group The New England Journal of Medicine 1993 329 14 977 986
2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group The Lancet 1998 352 9131 854 865
3. Middleton R. J., Foley R. N., Hegarty J., Cheung C. M., McElduff P., Gibson J. M., Kalra P. A., O'Donoghue D. J., New J. P., The unrecognized prevalence of chronic kidney disease in diabetes Nephrology Dialysis Transplantation 2006 21 1 88 92 (Pubitemid 43057115)
4. Brosius F. C. III, Alpers C. E., Bottinger E. P., Breyer M. D., Coffman T. M., Gurley S. B., Harris R. C., Kakoki M., Kretzler M., Leiter E. H., Levi M., McIndoe R. A., Sharma K., Smithies O., Susztak K., Takahashi N., Takahashi T., Mouse models of diabetic nephropathy Journal of the American Society of Nephrology 2009 20 12 2503 2512
5. Molitch M. E., DeFronzo R. A., Franz M. J., Nephropathy in diabetes Diabetes Care 2004 27 supplement 1 S79 S83
6. Lai F. M. M., Szeto C. C., Choi P. C. L., Ho K. K. L., Tang N. L. S., Chow K. M., Li P. K. T., To K. F., Isolate diffuse thickening of glomerular capillary basement membrane: a renal lesion in prediabetes? Modern Pathology 2004 17 12 1506 1512 (Pubitemid 39627077)
7. Mason R. M., Wahab N. A., Extracellular matrix metabolism in diabetic nephropathy Journal of the American Society of Nephrology 2003 14 5 1358 1373 (Pubitemid 36519197)
8. Ziyadeh F. N., Renal tubular basement membrane and collagen type IV in diabetes mellitus Kidney International 1993 43 1 114 120 (Pubitemid 23167454)
9. Nerlich A., Schleicher E., Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions American Journal of Pathology 1991 139 4 889 899
10. Ayo S. H., Radnik R. A., Garoni J. A., Glass W. F., Kreisberg J. I., High glucose causes an increase in extracellular matrix proteins in cultured mesangial cells American Journal of Pathology 1990 136 6 1339 1348 (Pubitemid 20210333)
11. Miner J. H., Renal basement membrane components Kidney International 1999 56 6 2016 2024 (Pubitemid 30004730)
12. Durbeej M., Laminins Cell and Tissue Research 2010 339 1 259 268
13. Miner J. H., Li C., Defective glomerulogenesis in the absence of laminin 5 demonstrates a developmental role for the kidney glomerular basement membrane Developmental Biology 2000 217 2 278 289 (Pubitemid 30060876)
14. Lee M. J., Feliers D., Mariappan M. M., Sataranatarajan K., Mahimainathan L., Musi N., Foretz M., Viollet B., Weinberg J. M., Choudhury G. G., Kasinath B. S., A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy American Journal of Physiology 2007 292 2 F617 F627
15. Mariappan M. M., Feliers D., Mummidi S., Choudhury G. G., Kasinath B. S., High glucose, high insulin, and their combination rapidly induce laminin- 1 synthesis by regulation of mRNA translation in renal epithelial cells Diabetes 2007 56 2 476 485
16. Kim Y., Kleppel M. M., Butkowski R., Mauer S. M., Wieslander J., Michael A. F., Differential expression of basement membrane collagen chains in diabetic nephropathy American Journal of Pathology 1991 138 2 413 420
17. Tsilibary E. C., Microvascular basement membranes in diabetes mellitus Journal of Pathology 2003 200 4 537 546 (Pubitemid 36818254)
18. Courtoy P. J., Kanwar Y. S., Hynes R. O., Farquhar M. G., Fibronectin localization in the rat glomerulus Journal of Cell Biology 1980 87 3 691 696 (Pubitemid 11161799)
19. Ruoslahti E., Engvall E., Hayman E. G., Fibronectin: current concepts of its structure and functions Collagen and Related Research 1981 1 1 95 128 (Pubitemid 11100236)
20. Chung A. E., Durkin M. E., Entactin: structure and function American Journal of Respiratory Cell and Molecular Biology 1990 3 4 275 282
21. Timpl R., Macromolecular organization of basement membranes Current Opinion in Cell Biology 1996 8 5 618 624 (Pubitemid 26381718)
22. Adler S., Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy Journal of the American Society of Nephrology 1994 5 5 1165 1172 (Pubitemid 24977097)
23. Han S. Y., Jee Y. H., Han K. H., Kang Y. S., Kim H. K., Han J. Y., Kim Y. S., Cha D. R., An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy Nephrology Dialysis Transplantation 2006 21 9 2406 2416 (Pubitemid 44644511)
24. Haneda M., Koya D., Isono M., Kikkawa R., Overview of glucose signaling in mesangial cells in diabetic nephropathy Journal of the American Society of Nephrology 2003 14 5 1374 1382 (Pubitemid 36514677)
25. Liu Y., Rajur K., Tolbert E., Dworkin L. D., Endogenous hepatocyte growth factor ameliorates chronic renal injury by activating matrix degradation pathways Kidney International 2000 58 5 2028 2043
26. Sanchez A. P., Sharma K., Transcription factors in the pathogenesis of diabetic nephropathy Expert Reviews in Molecular Medicine 2009 11, article e13
27. Bolster D. R., Jefferson L. S., Kimball S. R., Regulation of protein synthesis associated with skeletal muscle hypertrophy by insulin, amino acid- and exercise-induced signalling Proceedings of the Nutrition Society 2004 63 2 351 356 (Pubitemid 38787489)
28. Kasinath B. S., Mariappan M. M., Sataranatarajan K., Lee M. J., Feliers D., mRNA translation: unexplored territory in renal science Journal of the American Society of Nephrology 2006 17 12 3281 3292 (Pubitemid 44865271)
29. Ruggero D., Sonenberg N., The Akt of translational control Oncogene 2005 24 50 7426 7434 (Pubitemid 41637982)
30. Spruill L. S., McDermott P. J., Role of the 5′-untranslated region in regulating translational efficiency of specific mRNAs in adult cardiocytes The FASEB Journal 2009 23 9 2879 2887
31. Frost R. A., Lang C. H., mTor signaling in skeletal muscle during sepsis and inflammation: where does it all go wrong? Physiology 2011 26 3 83 96
32. Kasinath B. S., Feliers D., Sataranatarajan K., Choudhury G. G., Lee M. J., Mariappan M. M., Regulation of mRNA translation in renal physiology and disease American Journal of Physiology 2009 297 5 F1153 F1165
33. Proud C. G., mTORC1 signalling and mRNA translation Biochemical Society Transactions 2009 37 1 227 231
34. Sataranatarajan K., Mariappan M. M., Myung J. L., Feliers D., Choudhury G. G., Barnes J. L., Kasinath B. S., Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin American Journal of Pathology 2007 171 6 1733 1742
35. Feliers D., Duraisamy S., Barnes J. L., Ghosh-Choudhury G., Kasinath B. S., Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II American Journal of Physiology 2005 288 3 F521 F529
36. Boisvert F. M., Van Koningsbruggen S., Navascués J., Lamond A. I., The multifunctional nucleolus Nature Reviews Molecular Cell Biology 2007 8 7 574 585 (Pubitemid 46985376)
37. Warner J. R., Vilardell J., Sohn J. H., Economics of ribosome biosynthesis Cold Spring Harbor Symposia on Quantitative Biology 2001 66 567 574 (Pubitemid 36097963)
38. Lewis J. D., Tollervey D., Like attracts like: getting RNA processing together in the nucleus Science 2000 288 5470 1385 1389 (Pubitemid 30366318)
39. Drakas R., Tu X., Baserga R., Control of cell size through phosphorylation of upstream binding factor 1 by nuclear phosphatidylinositol 3-kinase Proceedings of the National Academy of Sciences of the United States of America 2004 101 25 9272 9276 (Pubitemid 38812865)
40. Kihm A. J., Hershey J. C., Haystead T. A. J., Madsen C. S., Owens G. K., Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein Proceedings of the National Academy of Sciences of the United States of America 1998 95 25 14816 14820 (Pubitemid 29003713)
41. Grummt I., Regulation of mammalian ribosomal gene transcription by RNA polymerase I Progress in Nucleic acid Research and Molecular Biology 1999 62 109 154
42. Mariappan M. M., D'Silva K., Lee M. J., Sataranatarajan K., Barnes J. L., Choudhury G. G., Kasinath B. S., Ribosomal biogenesis induction by high glucose requires activation of upstream binding factor in kidney glomerular epithelial cells American Journal of Physiology 2011 300 1 F219 F230
43. Polak P., Hall M. N., mTOR and the control of whole body metabolism Current Opinion in Cell Biology 2009 21 2 209 218
44. Dann S. G., Selvaraj A., Thomas G., mTOR Complex1-S6K1 signaling: at the crossroads of obesity, diabetes and cancer Trends in Molecular Medicine 2007 13 6 252 259 (Pubitemid 46836871)
45. Holz M. K., Ballif B. A., Gygi S. P., Blenis J., mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events Cell 2005 123 4 569 580 (Pubitemid 41608461)
46. Yanagiya A., Svitkin Y. V., Shibata S., Mikami S., Imataka H., Sonenberg N., Requirement of RNA binding of mammalian eukaryotic translation initiation factor 4GI (eIF4GI) for efficient interaction of eIF4E with the mRNA cap Molecular and Cellular Biology 2009 29 6 1661 1669
47. Gingras A. C., Kennedy S. G., O'Leary M. A., Sonenberg N., Hay N., 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway Genes and Development 1998 12 4 502 513 (Pubitemid 28101013)
48. Kasinath B. S., Mariappan M. M., Sataranatarajan K., Lee M. J., Ghosh Choudhury G., Feliers D., Novel mechanisms of protein synthesis in diabetic nephropathyrole of mRNA translation Reviews in Endocrine and Metabolic Disorders 2008 9 4 255 266
49. Korneeva N. L., Lamphear B. J., Hennigan F. L. C., Rhoads R. E., Mutually cooperative binding of eukaryotic translation initiation factor (eIF) 3 and eIF4A to human eIF4G-1 The Journal of Biological Chemistry 2000 275 52 41369 41376 (Pubitemid 32054972)
50. Pause A., Belsham G. J., Gingras A. C., Donze O., Lin T. A., Lawrence J. C., Sonenberg N., Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function Nature 1994 371 6500 762 767
51. Proud C. G., Signalling to translation: how signal transduction pathways control the protein synthetic machinery Biochemical Journal 2007 403 2 217 234 (Pubitemid 46596577)
52. Wang X., Li W., Williams M., Terada N., Alessi D. R., Proud C. G., Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase The EMBO Journal 2001 20 16 4370 4379 (Pubitemid 32772031)
53. Redpath N. T., Foulstone E. J., Proud C. G., Regulation of translation elongation factor-2 by insulin via a rapamycin-sensitive signalling pathway The EMBO Journal 1996 15 9 2291 2297 (Pubitemid 26141145)
54. Ha T. S., Barnes J. L., Stewart J. L., Ko C. W., Miner J. H., Abrahamson D. R., Sanes J. R., Kasinath B. S., Regulation of renal laminin in mice with type II diabetes Journal of the American Society of Nephrology 1999 10 9 1931 1939 (Pubitemid 29402514)
55. Ziyadeh F. N., Hoffman B. B., Han D. C., Iglesias-De La Cruz M. C., Hong S. W., Isono M., Chen S., McGowan T. A., Sharma K., Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor- antibody in db/db diabetic mice Proceedings of the National Academy of Sciences of the United States of America 2000 97 14 8015 8020 (Pubitemid 30460765)
56. Alessi D. R., Pearce L. R., Garca-Martnez J. M., New insights into mTOR signaling: mTORC2 and beyond Science Signaling 2009 2 67 pe27
57. Jacinto E., Facchinetti V., Liu D., Soto N., Wei S., Jung S. Y., Huang Q., Qin J., Su B., SIN1/MIP1 maintains rictor-mTOR complex integrity and regulates Akt phosphorylation and substrate specificity Cell 2006 127 1 125 137 (Pubitemid 44466632)
58. Sarbassov D. D., Guertin D. A., Ali S. M., Sabatini D. M., Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex Science 2005 307 5712 1098 1101 (Pubitemid 40262113)
59. Oh W. J., Wu C. C., Kim S. J., Facchinetti V., Julien L. A., Finlan M., Roux P. P., Su B., Jacinto E., MTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide The EMBO Journal 2010 29 23 3939 3951
60. Xie X., Guan K.-L., The ribosome and TORC2: collaborators for cell growth Cell 2011 144 5 640 642
61. Kramer G., Boehringer D., Ban N., Bukau B., The ribosome as a platform for co-translational processing, folding and targeting of newly synthesized proteins Nature Structural and Molecular Biology 2009 16 6 589 597
62. Lloberas N., Cruzado J. M., Franquesa M., Herrero-Fresneda I., Torras J., Alperovich G., Rama I., Vidal A., Griny J. M., Mammalian target of rapamycin pathway blockade slows progression of diabetic kidney disease in rats Journal of the American Society of Nephrology 2006 17 5 1395 1404 (Pubitemid 43673420)
63. Mori H., Inoki K., Masutani K., Wakabayashi Y., Komai K., Nakagawa R., Guan K. L., Yoshimura A., The mTOR pathway is highly activated in diabetic nephropathy and rapamycin has a strong therapeutic potential Biochemical and Biophysical Research Communications 2009 384 4 471 475
64. Sakaguchi M., Isono M., Isshiki K., Sugimoto T., Koya D., Kashiwagi A., Inhibition of mTOR signaling with rapamycin attenuates renal hypertrophy in the early diabetic mice Biochemical and Biophysical Research Communications 2006 340 1 296 301 (Pubitemid 41827680)
65. Yang Y., Wang J., Qin L., Shou Z., Zhao J., Wang H., Chen Y., Chen J., Rapamycin prevents early steps of the development of diabetic nephropathy in rats American Journal of Nephrology 2007 27 5 495 502 (Pubitemid 47482007)
66. Gdel M., Hartleben B., Herbach N., Liu S., Zschiedrich S., Lu S., Debreczeni-Mr A., Lindenmeyer M. T., Rastaldi M.-P., Hartleben G., Wiech T., Fornoni A., Nelson R. G., Kretzler M., Wanke R., Pavenstdt H., Kerjaschki D., Cohen C. D., Hall M. N., Regg M. A., Inoki K., Walz G., Huber T. B., Role of mTOR in podocyte function and diabetic nephropathy in humans and mice The Journal of Clinical Investigation 2011 121 6 2197 2209
67. Inoki K., Mori H., Wang J., Suzuki T., Hong S., Yoshida S., Blattner S. M., Ikenoue T., Regg M. A., Hall M. N., Kwiatkowski D. J., Rastaldi M. P., Huber T. B., Kretzler M., Holzman L. B., Wiggins R. C., Guan K. -L., mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice Journal of Clinical Investigation 2011 121 6 2181 2196
68. Chen J., Chen J. K., Neilson E. G., Harris R. C., Role of EGF receptor activation in angiotensin II-induced renal epithelial cell hypertrophy Journal of the American Society of Nephrology 2006 17 6 1615 1623 (Pubitemid 43794664)
69. Mariappan M. M., Senthil D., Natarajan K. S., Choudhury G. G., Kasinath B. S., Phospholipase C -Erk axis in vascular endothelial growth factor-induced eukaryotic initiation factor 4E phosphorylation and protein synthesis in renal epithelial cells The Journal of Biological Chemistry 2005 280 31 28402 28411 (Pubitemid 41105739)
70. Ding D. F., You N., Wu X. M., Xu J. R., Hu A. P., Ye X. L., Zhu Q., Jiang X. Q., Miao H., Liu C., Lu Y. B., Resveratrol attenuates renal hypertrophy in early-stage diabetes by activating AMPK American Journal of Nephrology 2010 31 4 363 374
71. Lee M. J., Feliers D., Sataranatarajan K., Mariappan M. M., Li M., Barnes J. L., Choudhury G. G., Kasinath B. S., Resveratrol ameliorates high glucose-induced protein synthesis in glomerular epithelial cells Cellular Signalling 2010 22 1 65 70
72. Ravid M., Brosh D., Levi Z., Bar-Dayan Y., Ravid D., Rachmani R., Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: a randomized, controlled trial Annals of Internal Medicine 1998 128 12 982 988 (Pubitemid 28275174)
73. Chan A. Y. M., Soltys C. L. M., Young M. E., Proud C. G., Dyck J. R. B., Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte The Journal of Biological Chemistry 2004 279 31 32771 32779 (Pubitemid 39014736)
74. Vyas D. R., Spangenburg E. E., Abraha T. W., Childs T. E., Booth F. W., GSK-3 negatively regulates skeletal myotube hypertrophy American Journal of Physiology 2002 283 2 C545 C551
75. Haq S., Choukroun G., Kang Z. B., Ranu H., Matsui T., Rosenzweig A., Molkentin J. D., Alessandrini A., Woodgett J., Hajjar R., Michael A., Force T., Glycogen synthase kinase-3 is a negative regulator of cardiomyocyte hypertrophy Journal of Cell Biology 2000 151 1 117 129
76. Hardt S. E., Sadoshima J., Glycogen synthase kinase-3 a novel regulator of cardiac hypertrophy and development Circulation Research 2002 90 10 1055 1063 (Pubitemid 34627903)
77. Deng H., Hershenson M. B., Lei J., Anyanwu A. C., Pinsky D. J., Kelley Bentley J., Pulmonary artery smooth muscle hypertrophy: roles of glycogen synthase kinase-3 and p70 ribosomal S6 kinase American Journal of Physiology 2010 298 6 L793 L803
78. Welsh G. I., Miller C. M., Loughlin A. J., Price N. T., Proud C. G., Regulation of eukaryotic initiation factor eIF2B: Glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin FEBS Letters 1998 421 2 125 130 (Pubitemid 28288076)
79. Preiss T., Hentze M. W., Starting the protein synthesis machine: Eukaryotic translation initiation BioEssays 2003 25 12 1201 1211 (Pubitemid 37499320)
80. Mariappan M. M., Shetty M., Sataranatarajan K., Choudhury G. G., Kasinath B. S., Glycogen synthase kinase 3 is a novel regulator of high glucose- and high insulin-induced extracellular matrix protein synthesis in renal proximal tubular epithelial cells The Journal of Biological Chemistry 2008 283 45 30566 30575
81. Antos C. L., McKinsey T. A., Frey N., Kutschke W., McAnally J., Shelton J. M., Richardson J. A., Hill J. A., Olson E. N., Activated glycogen synthase-3 suppresses cardiac hypertrophy in vivo Proceedings of the National Academy of Sciences of the United States of America 2002 99 2 907 912 (Pubitemid 34106609)
82. Boini K. M., Amann K., Kempe D., Alessi D. R., Lang F., Proteinuria in mice expressing PKB/SGK-resistant GSK3 American Journal of Physiology 2009 296 1 F153 F159
83. Proud C. G., Dynamic balancing: DEPTOR tips the scales Journal of Molecular Cell Biology 2009 1 2 61 63
84. Zoncu R., Efeyan A., Sabatini D. M., MTOR: from growth signal integration to cancer, diabetes and ageing Nature Reviews Molecular Cell Biology 2011 12 1 21 35
85. Peterson T. R., Laplante M., Thoreen C. C., Sancak Y., Kang S. A., Kuehl W. M., Gray N. S., Sabatini D. M., DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival Cell 2009 137 5 873 886
86. Liu M., Wilk S. A., Wang A., Zhou L., Wang R. H., Ogawa W., Deng C., Dong L. Q., Liu F., Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR The Journal of Biological Chemistry 2010 285 47 36387 36394
87. Kazi A. A., Hong-Brown L., Lang S. M., Lang C. H., Deptor knockdown enhances mTOR activity and protein synthesis in myocytes and ameliorates disuse muscle atrophy Molecular Medicine 2011 17 9-10 925 936
88. Sun Y., Koo S., White N., Peralta E., Esau C., Dean N. M., Perera R. J., Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs Nucleic Acids Research 2004 32 22, article e188
89. Kato M., Arce L., Wang M., Putta S., Lanting L., Natarajan R., A microRNA circuit mediates transforming growth factor-beta1 autoregulation in renal glomerular mesangial cells Kidney International 2011 80 4 358 368
90. Kato M., Zhang J., Wang M., Lanting L., Yuan H., Rossi J. J., Natarajan R., MicroRNA-192 in diabetic kidney glomeruli and its function in TGF- -induced collagen expression via inhibition of E-box repressors Proceedings of the National Academy of Sciences of the United States of America 2007 104 9 3432 3437 (Pubitemid 46364176)
91. Wang Q., Wang Y., Minto A. W., Wang J., Shi Q., Li X., Quigg R. J., MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy The FASEB Journal 2008 22 12 4126 4135
92. Long J., Wang Y., Wang W., Chang B. H. J., Danesh F. R., MicroRNA-29c is a signature MicroRNA under high glucose conditions that targets sprouty homolog 1, and its in vivo knockdown prevents progression of diabetic nephropathy The Journal of Biological Chemistry 2011 286 13 11837 11848
93. Selbach M., Schwanhusser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N., Widespread changes in protein synthesis induced by microRNAs Nature 2008 455 7209 58 63
94. Behm-Ansmant I., Rehwinkel J., Izaurralde E., MicroRNAs silence gene expression by repressing protein expression and/or by promoting mRNA decay Cold Spring Harbor Symposia on Quantitative Biology 2006 71 523 530
95. Doench J. G., Sharp P. A., Specificity of microRNA target selection in translational repression Genes and Development 2004 18 5 504 511 (Pubitemid 38372808)
96. Dey N., Das F., Mariappan M. M., Mandal C. C., Ghosh-Choudhury N., Kasinath B. S., Choudhury G. G., MicroRNA-21 orchestrates high glucose-induced signals to TOR complex 1, resulting in renal cell pathology in diabetes The Journal of Biological Chemistry 2011 286 29 25586 25603
97. Kasinath B. S., Feliers D., The complex world of kidney microRNAs Kidney International 2011 80 4 334 337
98. Reddy M. A., Natarajan R., Epigenetic mechanisms in diabetic vascular complications Cardiovascular Research 2011 90 3 421 429
99. Cooper M. E., El-Osta A., Epigenetics: mechanisms and implications for diabetic complications Circulation Research 2010 107 12 1403 1413
100. Tonna S., El-Osta A., Cooper M. E., Tikellis C., Metabolic memory and diabetic nephropathy: potential role for epigenetic mechanisms Nature Reviews Nephrology 2010 6 6 332 341
101. Villeneuve L. M., Reddy M. A., Natarajan R., Epigenetics: deciphering its role in diabetes and its chronic complications Clinical and Experimental Pharmacology and Physiology 2011 38 7 401 409
102. Allen T. J., Cooper M. E., Lan H. Y., Use of genetic mouse models in the study of diabetic nephropathy Current Atherosclerosis Reports 2004 6 3 197 202 (Pubitemid 38898918)
103. Srinivasan K., Ramarao P., Animal models in type 2 diabetes research: an overview Indian Journal of Medical Research 2007 125 3 451 472 (Pubitemid 46805458)
104. Cohen M. P., Clements R. S., Hud E., Cohen J. A., Ziyadeh F. N., Evolution of renal function abnormalities in the db/db mouse that parallels the development of human diabetic nephropathy Experimental Nephrology 1996 4 3 166 171 (Pubitemid 26162138)
105. Feliers D., Duraisamy S., Faulkner J. L., Duch J., Lee A. V., Abboud H. E., Ghosh Choudhury G., Kasinath B. S., Activation of renal signaling pathways in db/db mice with type 2 diabetes Kidney International 2001 60 2 495 504 (Pubitemid 32678893)
106. Chen L. M., Li X. W., Huang L. W., Li Y., Duan L., Zhang X. J., The early pathological changes of KKAy mice with type 2 diabetes Acta Academiae Medicinae Sinicae 2002 24 1 71 75
107. Hagiwara S., Makita Y., Gu L., Tanimoto M., Zhang M., Nakamura S., Kaneko S., Itoh T., Gohda T., Horikoshi S., Tomino Y., Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation Nephrology Dialysis Transplantation 2006 21 3 605 615 (Pubitemid 43372905)
108. Okazaki M., Saito Y., Udaka Y., Maruyama M., Murakami H., Ota S., Kikuchi T., Oguchi K., Diabetic nephropathy in KK and KK-Ay mice Experimental Animals 2002 51 2 191 196
109. Kim C.-H., Pennisi P., Zhao H., Yakar S., Kaufman J. B., Iganaki K., Shiloach J., Scherer P. E., Quon M. J., LeRoith D., MKR mice are resistant to the metabolic actions of both insulin and adiponectin: discordance between insulin resistance and adiponectin responsiveness American Journal of Physiology 2006 291 2 E298 E305
110. Fernndez A. M., Kim J. K., Yakar S., Dupont J., Hernandez-Sanchez C., Castle A. L., Filmore J., Shulman G. I., Le Roith D., Functional inactivation of the IGF-I and insulin receptors in skeletal muscle causes type 2 diabetes Genes and Development 2001 15 15 1926 1934 (Pubitemid 32738622)
111. Mauer M., Zinman B., Gardiner R., Drummond K. N., Suissa S., Donnelly S. M., Strand T. D., Kramer M. S., Klein R., Sinaiko A. R., ACE-I and ARBs in early diabetic nephropathy JRAAS 2002 3 4 262 269 (Pubitemid 36181996)
112. Davis L. K., Rodgers B. D., Kelley K. M., Angiotensin II- and glucose-stimulated extracellular matrix production: mediation by the insulin-like growth factor (IGF) axis in a murine mesangial cell line Endocrine 2008 33 1 32 39
113. Sharma K., Ix J. H., Mathew A. V., Cho M., Pflueger A., Dunn S. R., Francos B., Sharma S., Falkner B., McGowan T. A., Donohue M., RamachandraRao S., Xu R., Fervenza F. C., Kopp J. B., Pirfenidone for diabetic nephropathy Journal of the American Society of Nephrology 2011 22 6 1144 1151
114. Nakao N., Yoshimura A., Morita H., Takada M., Kayano T., Ideura T., Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial The Lancet 2003 361 9352 117 124 (Pubitemid 36092015)
115. Thomas M. C., Groop P.-H., New approaches to the treatment of nephropathy in diabetes Expert Opinion on Investigational Drugs 2011 20 8 1057 1071